Abstract Purpose of the Review Evidence is rapidly accumulating implicating gut dysbiosis
in hypertension (HTN). However, we are far from understanding whether this is a cause or …

Hypertension is the most prevalent modifiable risk factor for cardiovascular disease and
disorders directly influencing cardiovascular disease morbidity and mortality, such as …

Hypertension affects an estimated 103 million Americans, yet gaps in knowledge continue to
limit its successful management. Rapidly emerging evidence is linking gut dysbiosis to many …

Rationale: Sympathetic nervous system control of inflammation plays a central role in
hypertension. The gut receives significant sympathetic innervation, is densely populated …

Recent evidence indicates a link between gut pathology and microbiome with hypertension
(HTN) in animal models. However, whether this association exists in humans is unknown …

We read with interest the recent work by Uhde et al, 1 which demonstrated that physically
asymptomatic non-coeliac gluten/wheat sensitivity involves compromised intestinal …

Rationale: Microglial activation in autonomic brain regions is a hallmark of
neuroinflammation in neurogenic hypertension. Despite evidence that an impaired …

Pulmonary arterial hypertension (PAH) is considered a disease of the pulmonary
vasculature. Limited progress has been made in preventing or arresting progression of PAH …

The National Aeronautics and Space Administration Soil Moisture Active Passive (SMAP)
mission has been validating its soil moisture (SM) products since the start of data production …

Introduction Increased gut permeability (“leaky gut”) has been proposed as a potential
contributor to age-related inflammation and gut dysbiosis. However, information on the …